284 related articles for article (PubMed ID: 18329278)
1. Peripheral nerve damage associated with administration of taxanes in patients with cancer.
Argyriou AA; Koltzenburg M; Polychronopoulos P; Papapetropoulos S; Kalofonos HP
Crit Rev Oncol Hematol; 2008 Jun; 66(3):218-28. PubMed ID: 18329278
[TBL] [Abstract][Full Text] [Related]
2. Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
Argyriou AA; Zolota V; Kyriakopoulou O; Kalofonos HP
J BUON; 2010; 15(3):435-46. PubMed ID: 20941808
[TBL] [Abstract][Full Text] [Related]
3. A review on oxaliplatin-induced peripheral nerve damage.
Argyriou AA; Polychronopoulos P; Iconomou G; Chroni E; Kalofonos HP
Cancer Treat Rev; 2008 Jun; 34(4):368-77. PubMed ID: 18281158
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
[TBL] [Abstract][Full Text] [Related]
5. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.
Argyriou AA; Iconomou G; Kalofonos HP
Blood; 2008 Sep; 112(5):1593-9. PubMed ID: 18574024
[TBL] [Abstract][Full Text] [Related]
7. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Amara S
Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.
Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander M; Kiernan MC
Curr Med Chem; 2008; 15(29):3081-94. PubMed ID: 19075655
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathy induced by microtubule-stabilizing agents.
Lee JJ; Swain SM
J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
[TBL] [Abstract][Full Text] [Related]
11. Role of erythropoeitin in prevention of chemotherapy-induced peripheral neuropathy.
Kassem LA; Yassin NA
Pak J Biol Sci; 2010 Jun; 13(12):577-87. PubMed ID: 21061908
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy.
Hilkens PH; ven den Bent MJ
J Peripher Nerv Syst; 1997; 2(4):350-61. PubMed ID: 10975744
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
15. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
16. Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.
Rivera E; Cianfrocca M
Cancer Chemother Pharmacol; 2015 Apr; 75(4):659-70. PubMed ID: 25596818
[TBL] [Abstract][Full Text] [Related]
17. The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats.
Cervellini I; Bello E; Frapolli R; Porretta-Serapiglia C; Oggioni N; Canta A; Lombardi R; Camozzi F; Roglio I; Melcangi RC; D'incalci M; Lauria G; Ghezzi P; Cavaletti G; Bianchi R
Neurotox Res; 2010 Aug; 18(2):151-60. PubMed ID: 19876698
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of taxane neuropathy.
Kudlowitz D; Muggia F
Anticancer Drugs; 2014 May; 25(5):495-501. PubMed ID: 24300917
[TBL] [Abstract][Full Text] [Related]
19. Incidence and risk of peripheral neuropathy with nab-paclitaxel in patients with cancer: a meta-analysis.
Peng L; Bu Z; Ye X; Zhou Y; Zhao Q
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26537178
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.
Fumagalli G; Monza L; Cavaletti G; Rigolio R; Meregalli C
Front Immunol; 2020; 11():626687. PubMed ID: 33613570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
